Company intelligence / Profile preview

Oysco

Utrecht, Utrecht, Netherlandsoysco.com ↗

Ownership: Private
Development stage: Other

Overview

Oysco is a biotechnology company based in the Netherlands that focuses on the development of senolytic therapies to treat age-related diseases. The company's primary research centers on identifying and eliminating senescent cells, which are known to contribute to chronic inflammation and tissue dysfunction. By targeting these "zombie cells," Oysco aims to restore tissue health and improve outcomes for conditions such as fibrosis and other degenerative disorders. The company is currently in the pre-clinical stage, advancing its lead compounds through early-stage validation and optimization.

Therapeutic areas: ImmunologyOther
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Oysco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oysco.

Explore the full profile